FTC Commissioner Changes Could Impact Pharma Mergers, Scrutiny Of Biosimilars Uptake

 
• By Brenda Sandburg

President Biden’s picks to fill two commissioner posts may shift dynamics on pharmaceutical industry enforcement. Rohit Chopra’s nomination to Consumer Financial Protection Bureau removes strong critic of pharma mergers.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.
President Biden to fill two FTC commissioner posts • Source: Shutterstock

More from Compliance

More from Pink Sheet